Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy

• Main Authors: Yang Jiaying (Author), Sun Bo (Author), Wei Xiaolu (Author), Zhou Yanyan (Author), Wang Hongjie (Author), Si Nan (Author), Gao Bo (Author), Wang Linna (Author), Zhang Yan (Author), Gao Wenya (Author), Luo Keke (Author), Jiang Shan (Author), Luo Chuan (Author), Zhao Yu (Author), Zhao Qinghe (Author), Zhao Haiyu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

AbstractArenobufagin (ArBu) is a natural anticancer drug with good anti-tumor effects, but its clinical applications and drug development potential are limited due to its toxicity. The purpose of this study is to reduce the toxic side effects of ArBu and improve the efficacy of tumor treatment by in...